Literature DB >> 7379920

N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.

E Arrigoni-Martelli, C K Nielsen, U B Olsen, H J Petersen.   

Abstract

N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134) is a new agent which induces a marked and sustained hypotensive response in normotensive and renal, neurogenic, and spontaneously hypertensive rats, as well as in normotensive and renal hypertensive dogs. The overall potency of this compound is 2-3 times greater than that of hydralazine. The fall of blood pressure is accompanied by an increase in heart rate and cardiac output and a decrease in total peripheral resistance. The hypotensive effect appears to be due primarily to a direct relaxant effect on vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379920     DOI: 10.1007/bf01975139

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  10 in total

1.  NEUROGENIC HYPERTENSION IN THE RAT.

Authors:  E M KRIEGER
Journal:  Circ Res       Date:  1964-12       Impact factor: 17.367

2.  Acute circulatory effects of diazoxide and sodium nitrite.

Authors:  A A RUBIN; L ZITOWITZ; L HAUSLER
Journal:  J Pharmacol Exp Ther       Date:  1963-04       Impact factor: 4.030

Review 3.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

Review 4.  Measurement of blood flow by thermodilution.

Authors:  W Ganz; H J Swan
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

5.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

6.  Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.

Authors:  C Carpi; L Dorigotti
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

Review 7.  Control of resistance, exchange, and capacitance functions in the peripheral circulation.

Authors:  S Mellander; B Johansson
Journal:  Pharmacol Rev       Date:  1968-09       Impact factor: 25.468

8.  Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.

Authors:  H J Petersen; C K Nielsen; E Arrigoni-Martelli
Journal:  J Med Chem       Date:  1978-08       Impact factor: 7.446

9.  [Experimental studies on the effects of the hypotension provoking hydrazinophthalazine derivatives apresoline and nepresol on blood circulation].

Authors:  H J BEIN; F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1953-04-04

10.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

  10 in total
  34 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.

Authors:  L M Sassen; D J Duncker; B C Gho; H W Diekmann; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 3.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 4.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

5.  Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.

Authors:  J E Carlsen; H A Jensen; M Rehling; J O Lund; J Trap-Jensen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Pinacidil. Preclinical investigations.

Authors:  I Ahnfelt-Rønne
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.

Authors:  G Muiesan; R Fariello; M L Muiesan; O E Christensen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Acute haemodynamic effects of pinacidil in man.

Authors:  D P Nicholls; J G Murtagh; M E Scott; P Morton; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

9.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.

Authors:  C N Corder; M R Goldberg; P A Alaupovic; M D Price; S S Furste
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.